NASDAQ : STRO
Sutro Biopharma, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 9.1 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 150.89M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Sutro Biopharma, Inc. (STRO) reported revenue of 45.70M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 45.70M | 102.48M | 62.04M | 153.73M | 67.77M | 61.88M |
| Cost of Revenue | 144.74M | 166.42M | 252.04M | 180.43M | 137.17M | 104.40M |
| Gross Profit | -99.04M | -63.93M | -190.00M | -26.69M | -69.40M | -42.52M |
| Selling, General & Admin | 32.82M | 41.02M | 48.45M | 62.58M | 59.54M | 56.00M |
| Operating Expenses | 32.82M | 41.02M | 48.45M | 62.58M | 59.54M | 56.00M |
| Operating Income | -131.86M | -104.95M | -238.45M | -89.28M | -128.94M | -98.52M |
| Interest Expense | -41.58M | -42.06M | -31.07M | -23.75M | -7.42M | -3.20M |
| Interest & Investment Income | 6.90M | 9.25M | 18.64M | 14.51M | 3.46M | 577.00K |
| Other Non Operating Income (Expenses) | -6.32M | 63.00K | ||||
| EBT Excluding Unusual Items | -166.54M | -137.76M | -257.20M | -98.52M | -132.91M | -101.08M |
| Merger & Restructuring Charges | -14.19M | -53.41M | ||||
| Gain (Loss) on Sale of Investments | 32.10M | 9.92M | 16.20M | -4.45M | ||
| Pretax Income | -180.73M | -191.18M | -225.10M | -88.60M | -116.70M | -105.54M |
| Income Tax Expense | -96.00K | -93.00K | 2.36M | 18.19M | 2.50M | |
| Net Income | -180.64M | -191.09M | -227.46M | -106.79M | -119.20M | -105.54M |
| Net Income to Common | -180.64M | -191.09M | -227.46M | -106.79M | -119.20M | -105.54M |
| Shares Outstanding (Basic) | 11.67M | 8.50M | 7.74M | 6.02M | 5.07M | 4.61M |
| Shares Outstanding (Diluted) | 11.67M | 8.50M | 7.74M | 6.02M | 5.07M | 4.61M |
| EPS (Basic) | -15.47 | -22.49 | -29.40 | -17.75 | -23.49 | -22.88 |
| EPS (Diluted) | -15.47 | -22.49 | -29.40 | -17.75 | -23.49 | -22.88 |
| Free Cash Flow | -145.62M | -178.93M | -194.64M | -115.93M | -4.31M | -97.00M |
| Free Cash Flow Per Share | -12.47 | -21.06 | -25.16 | -19.27 | -0.85 | -21.03 |
| Gross Margin | -216.71% | -62.38% | -17.36% | -102.40% | -68.71% | |
| Operating Margin | -288.52% | -102.41% | -384.33% | -58.07% | -190.26% | -159.22% |
| Profit Margin | -395.25% | -186.45% | -366.62% | -69.47% | -175.89% | -170.55% |
| Free Cash Flow Margin | -318.63% | -174.59% | -313.72% | -75.41% | -6.36% | -156.76% |
| EBITDA | -125.80M | -97.63M | -231.24M | -82.46M | -123.25M | -93.68M |
| EBITDA Margin | -275.25% | -95.26% | -53.64% | -181.86% | -151.39% | |
| D&A For EBITDA | 6.06M | 7.32M | 7.22M | 6.82M | 5.69M | 4.84M |
| EBIT | -131.86M | -104.95M | -238.45M | -89.28M | -128.94M | -98.52M |
| EBIT Margin | -288.52% | -102.41% | -58.07% | -190.26% | -159.22% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 54.34M | 58.13M | 190.30M | 69.27M | 47.25M | 30.41M |
| Short-Term Investments | 110.01M | 83.30M | 126.59M | 306.35M | 287.11M | 167.52M |
| Cash & Short-Term Investments | 164.35M | 141.43M | 316.89M | 375.62M | 334.36M | 197.94M |
| Receivables | 5.80M | 3.98M | 8.62M | 36.08M | 7.12M | 12.45M |
| Prepaid Expenses | 5.50M | 5.52M | 17.80M | 9.85M | 11.67M | 8.12M |
| Total Current Assets | 175.65M | 150.93M | 343.31M | 421.54M | 353.15M | 218.51M |
| Property, Plant & Equipment | 16.82M | 21.55M | 35.87M | 44.76M | 51.06M | 51.59M |
| Long-Term Investments | 68.78M | |||||
| Other Long-Term Assets | 1.99M | 1.35M | 8.03M | 4.44M | 2.73M | 2.53M |
| Total Assets | 194.46M | 173.83M | 387.21M | 470.74M | 406.94M | 341.41M |
| Accounts Payable | 3.36M | 7.57M | 10.47M | 9.44M | 4.80M | 6.01M |
| Accrued Expenses | 22.19M | 33.71M | 40.13M | 34.10M | 24.83M | 17.07M |
| Current Portion of Long-Term Debt | 4.06M | 12.50M | 9.38M | |||
| Current Portion of Leases | 6.66M | 7.78M | 7.48M | 6.42M | 4.58M | 1.04M |
| Current Income Taxes Payable | 18.00K | 15.16M | ||||
| Current Unearned Revenue | 6.46M | 10.56M | 69.78M | 20.67M | 16.76M | 5.50M |
| Other Current Liabilities | 14.23M | 15.51M | 4.01M | 3.90M | 3.08M | 2.75M |
| Total Current Liabilities | 52.90M | 75.13M | 131.89M | 93.75M | 66.55M | 41.74M |
| Long-Term Debt | 3.77M | 15.74M | ||||
| Long-Term Leases | 4.12M | 7.89M | 15.67M | 23.15M | 29.57M | 31.22M |
| Long-Term Unearned Revenue | 239.06M | 221.56M | 193.34M | 202.49M | 89.89M | |
| Other Long-Term Liabilities | 1.69M | 1.69M | 1.69M | 1.69M | 119.00K | 146.00K |
| Total Liabilities | 297.78M | 306.28M | 342.61M | 321.09M | 189.90M | 88.84M |
| Common Stock | 17.00K | 9.00K | 8.00K | 61.00K | 58.00K | 46.00K |
| Additional Paid-In Capital | 951.70M | 845.48M | 831.42M | 708.98M | 670.22M | 586.24M |
| Retained Earnings | -1.05B | -977.96M | -786.87M | -559.41M | -452.62M | -333.41M |
| Comprehensive Income & Other | -58.00K | 19.00K | 39.00K | 21.00K | -618.00K | -314.00K |
| Total Common Equity | -103.32M | -132.45M | 44.60M | 149.65M | 217.05M | 252.56M |
| Shareholders' Equity | -103.32M | -132.45M | 44.60M | 149.65M | 217.05M | 252.56M |
| Total Liabilities & Equity | 194.46M | 173.83M | 387.21M | 470.74M | 406.94M | 341.41M |
| Total Debt | 10.78M | 15.67M | 23.15M | 33.63M | 50.43M | 57.37M |
| Net Cash (Debt) | 153.56M | 125.75M | 293.74M | 341.98M | 283.93M | 209.34M |
| Net Cash Per Share | 13.15 | 14.80 | 37.97 | 56.84 | 55.96 | 45.39 |
| Filing Date Shares Outstanding | 16.58M | 16.57M | 8.38M | 6.24M | 6.02M | 4.64M |
| Total Common Shares Outstanding | 16.58M | 8.58M | 8.25M | 6.10M | 5.75M | 4.63M |
| Working Capital | 122.75M | 75.79M | 211.42M | 327.80M | 286.61M | 176.78M |
| Book Value Per Share | -6.23 | -15.43 | 5.40 | 24.53 | 37.75 | 54.52 |
| Tangible Book Value | -103.32M | -132.45M | 44.60M | 149.65M | 217.05M | 252.56M |
| Tangible Book Value Per Share | -6.23 | -15.43 | 5.40 | 24.53 | 37.75 | 54.52 |
| Machinery | 25.51M | 42.12M | 40.00M | 37.63M | 31.82M | |
| Construction In Progress | 151.00K | 497.00K | 497.00K | 1.69M | 506.00K | |
| Leasehold Improvements | 12.34M | 24.20M | 23.61M | 23.21M | 23.65M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -180.64M | -191.09M | -227.46M | -106.79M | -119.20M | -105.54M |
| Depreciation & Amortization | 6.06M | 7.32M | 7.22M | 6.82M | 5.69M | 4.84M |
| Asset Writedown & Restructuring Costs | 1.69M | 1.69M | ||||
| Loss (Gain) From Sale of Investments | -2.18M | -3.44M | -41.86M | -18.99M | -16.57M | 7.24M |
| Stock-Based Compensation | 6.78M | 14.01M | 24.69M | 24.91M | 26.30M | 23.24M |
| Other Operating Activities | 44.50M | 44.66M | 36.97M | 16.82M | 2.92M | 6.16M |
| Change in Accounts Receivable | 2.20M | 4.64M | 27.46M | -28.96M | 5.34M | -6.89M |
| Change in Accounts Payable | -974.00K | -2.47M | 706.00K | 4.81M | -1.23M | 2.71M |
| Change in Unearned Revenue | -12.41M | -69.73M | 7.84M | -32.60M | 93.65M | -15.21M |
| Change in Other Net Operating Assets | -10.20M | 17.16M | -27.11M | 22.37M | 6.64M | 1.77M |
| Operating Cash Flow | -145.17M | -177.23M | -191.54M | -111.62M | 3.55M | -81.68M |
| Capital Expenditures | -446.00K | -1.70M | -3.10M | -4.32M | -7.86M | -15.32M |
| Investment in Securities | 33.23M | 46.71M | 221.61M | 391.00K | -27.17M | -82.00M |
| Other Investing Activities | 9.00K | 9.00K | ||||
| Investing Cash Flow | 32.79M | 45.01M | 218.51M | -3.92M | -35.02M | -97.31M |
| Long-Term Debt Repaid | -4.08M | -12.50M | -9.38M | |||
| Net Debt Issued (Repaid) | -4.08M | -12.50M | -9.38M | |||
| Issuance of Common Stock | 102.95M | 376.00K | 98.65M | 14.34M | 58.15M | 4.25M |
| Repurchase of Common Stock | -252.00K | -332.00K | -509.00K | -490.00K | -463.00K | -994.00K |
| Other Financing Activities | 136.21M | |||||
| Financing Cash Flow | 102.69M | 44.00K | 94.05M | 137.55M | 48.31M | 3.26M |
| Net Cash Flow | -9.69M | -132.17M | 121.02M | 22.01M | 16.84M | -175.74M |
| Free Cash Flow | -145.62M | -178.93M | -194.64M | -115.93M | -4.31M | -97.00M |
| Free Cash Flow Margin | -318.63% | -174.59% | -313.72% | -75.41% | -6.36% | -156.76% |
| Free Cash Flow Per Share | -12.47 | -21.06 | -25.16 | -19.27 | -0.85 | -21.03 |
| Levered Free Cash Flow | -100.76M | -112.39M | -78.99M | -36.57M | -41.16M | -59.62M |
| Unlevered Free Cash Flow | -74.77M | -86.10M | -59.57M | -21.72M | -36.53M | -57.62M |
| Cash Interest Paid | 310.00K | 1.13M | 1.87M | 2.05M | ||
| Cash Income Tax Paid | -75.00K | 17.52M | 379.00K | 103.00K | ||
| Change in Working Capital | -21.39M | -50.40M | 8.90M | -34.38M | 104.41M | -17.62M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 151.05M | 98.57M | 151.72M | 261.49M | 464.40M | 688.50M |
| Enterprise Value | -2.51M | -51.36M | -211.67M | -55.49M | 193.11M | 453.00M |
| Last Close Price | 9.11 | 11.57 | 18.40 | 42.90 | 80.80 | 148.80 |
| PS Ratio | 3.31 | 0.96 | 2.44 | 1.70 | 6.85 | 11.13 |
| PB Ratio | -0.74 | 3.40 | 1.75 | 2.14 | 2.73 | |
| P/TBV Ratio | 3.40 | 1.75 | 2.14 | 2.73 | ||
| P/OCF Ratio | 130.85 | |||||
| EV/Sales Ratio | 2.85 | 7.32 | ||||
| Debt / Equity Ratio | -0.10 | -0.12 | 0.52 | 0.23 | 0.23 | 0.23 |
| Net Debt / Equity Ratio | 1.49 | 0.95 | -6.59 | -2.29 | -1.31 | -0.83 |
| Net Debt / EBITDA Ratio | 1.22 | 1.29 | 1.27 | 4.15 | 2.30 | 2.23 |
| Net Debt / FCF Ratio | 1.05 | 0.70 | 1.51 | 2.95 | 65.89 | 2.16 |
| Asset Turnover | 0.20 | 0.36 | 0.14 | 0.35 | 0.18 | 0.17 |
| Quick Ratio | 3.22 | 1.94 | 2.47 | 4.39 | 5.13 | 5.04 |
| Current Ratio | 3.32 | 2.01 | 2.60 | 4.50 | 5.31 | 5.24 |
| Return on Equity (ROE) | -234.19% | -58.25% | -50.77% | -36.10% | ||
| Return on Assets (ROA) | -36.08% | -23.38% | -34.74% | -12.72% | -21.54% | -16.74% |
| Return on Capital Employed (ROCE) | -93.10% | -106.30% | -93.40% | -23.70% | -37.90% | -32.90% |
| Earnings Yield | -169.84% | -193.86% | -149.92% | -40.84% | -25.67% | -15.33% |
| FCF Yield | -96.40% | -181.52% | -128.28% | -44.34% | -0.93% | -14.09% |
| Buyback Yield / Dilution | -38.81% | -9.84% | -28.59% | -18.57% | -10.02% | -41.59% |